0001437749-23-017587.txt : 20230615 0001437749-23-017587.hdr.sgml : 20230615 20230615183506 ACCESSION NUMBER: 0001437749-23-017587 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scott John K Jr. CENTRAL INDEX KEY: 0001753763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 231018907 MAIL ADDRESS: STREET 1: 30 BLUE HERON DR. CITY: GREENWOOD VILLAGE STATE: CO ZIP: 80121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 rdgdoc.xml FORM 4 SCOTT 06.15.23 X0407 4 2023-06-01 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001753763 Scott John K Jr. 4995 BRADENTON AVE., SUITE 240 DUBLIN OH 43017 1 1 0 Series G Redeemable Preferred Stock 2023-06-01 4 J 0 990 D 2270 D Common Stock 2023-06-05 4 A 0 11508672 A 19555832 D Common Stock 10139 I By spouse and children Series J Convertible Preferred Stock 0.1040 2023-06-01 4 P 0 11969 100 A 2023-06-01 Common Stock 11508672 11969 D Series J Convertible Preferred Stock 0.1040 2023-06-05 4 C 0 11969 100 D 2023-06-01 Common Stock 11508672 0 D Navidea entered into a Stock Exchange Agreement with the Reporting Person, pursuant to which he surrendered 990 shares of Series G Redeemable Preferred Stock, par value $.001 per share, and $68,853.22 of accrued and unpaid dividends thereon in exchange for 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share. Series J Convertible Preferred Stock, par value $.001 per share was converted into Common Stock. Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares. Series J Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date. The Reporting Person converted 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share, into 11,508,672 shares of Common Stock. /s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney 2023-06-15